Signet Therapeutics
PrivateLast Round
Series A
Jan 14, 2026
Total Funding Raised
$50.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Signet Therapeutics is a biotechnology company that develops first-in-class targeted cancer therapies using organoids and AI.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signet Therapeutics Comparables
Compare Signet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orakl Oncology | 79% | |
| Sightera Biosciences | 77% | |
| ProxyBio | 77% |
Signet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2026 | ||||
| Pre Seed | Dec 3, 2024 | ||||
| Seed | Oct 29, 2021 | ||||
| Pre Seed | May 1, 2021 | ||||
| Angel | Mar 5, 2021 |
Signet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yael Capital | Seed |
| Tiantu Capital | Seed, Series A, Pre Seed, Angel |
| Sky9 Capital | Seed, Angel, Pre Seed |
| Blue Ocean Capital Group | Seed, Series A |
| 5Y Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 312% MoM, reaching 3.2K.
- Jul 20, 2026
Open roles increased to 12, 200% of headcount.
Signet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Signet Therapeutics's valuation, stock price, and market status.
Is Signet Therapeutics a public or private company?
Signet Therapeutics is a private company.
What is the current stock price of Signet Therapeutics?
Signet Therapeutics is a private company, so its shares have no public market price. Caplight tracks Signet Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signet Therapeutics worth (valuation)?
Valuation information for Signet Therapeutics is not publicly available.
Can I buy Signet Therapeutics stock?
Signet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signet Therapeutics's last funding round?
Signet Therapeutics's most recent funding round was Series A on January 14, 2026.
Who are the main investors in Signet Therapeutics?
Key investors in Signet Therapeutics include Tiantu Capital, 5Y Capital.
Will Signet Therapeutics IPO soon?
No public IPO plans have been announced for Signet Therapeutics.
How can I track Signet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Signet Therapeutics's shares on secondary markets.